You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and China Rosacea Treatments Market Size, Status and Forecast 2021-2027

Rosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half the patients experience eye dryness, irritation and swollen, reddened eyelids. Other symptoms include enlarged nose, thickening the skin on the nose, (rhinophyma). Rosacea predominantly affects middle-aged women having fair skin.

Americas is the largest Rosacea Treatments market with about 62% market share. Europe is follower, accounting for about 24% market share.
The key players are Nestle Skin Health, Teva, Mylan, Bayer, Sun Pharma, Perrigo, Bausch Health, GSK, Pfizer, Allergan, Almirall etc. Top 3 companies occupied about 38% market share.
Market Analysis and Insights: Global Rosacea Treatments Market
The global Rosacea Treatments market size is projected to reach US$ 16 million by 2027, from US$ 13 million in 2020, at a CAGR of 3.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rosacea Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rosacea Treatments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rosacea Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rosacea Treatments market.
Rosacea Treatments Breakdown Data by Type
Rosacea Treatments Breakdown Data by Application
Drugs Stores
Based on regional and country-level analysis, the Rosacea Treatments market has been segmented as follows:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Rosacea Treatments market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:
Nestle Skin Health
Sun Pharma
Bausch Health

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rosacea Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Topical
1.2.3 Orals
1.3 Market by Application
1.3.1 Global Rosacea Treatments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drugs Stores
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rosacea Treatments Market Perspective (2016-2027)
2.2 Rosacea Treatments Growth Trends by Regions
2.2.1 Rosacea Treatments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rosacea Treatments Historic Market Share by Regions (2016-2021)
2.2.3 Rosacea Treatments Forecasted Market Size by Regions (2022-2027)
2.3 Rosacea Treatments Industry Dynamic
2.3.1 Rosacea Treatments Market Trends
2.3.2 Rosacea Treatments Market Drivers
2.3.3 Rosacea Treatments Market Challenges
2.3.4 Rosacea Treatments Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rosacea Treatments Players by Revenue
3.1.1 Global Top Rosacea Treatments Players by Revenue (2016-2021)
3.1.2 Global Rosacea Treatments Revenue Market Share by Players (2016-2021)
3.2 Global Rosacea Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rosacea Treatments Revenue
3.4 Global Rosacea Treatments Market Concentration Ratio
3.4.1 Global Rosacea Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rosacea Treatments Revenue in 2020
3.5 Rosacea Treatments Key Players Head office and Area Served
3.6 Key Players Rosacea Treatments Product Solution and Service
3.7 Date of Enter into Rosacea Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rosacea Treatments Breakdown Data by Type
4.1 Global Rosacea Treatments Historic Market Size by Type (2016-2021)
4.2 Global Rosacea Treatments Forecasted Market Size by Type (2022-2027)

5 Rosacea Treatments Breakdown Data by Application
5.1 Global Rosacea Treatments Historic Market Size by Application (2016-2021)
5.2 Global Rosacea Treatments Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rosacea Treatments Market Size (2016-2027)
6.2 North America Rosacea Treatments Market Size by Type
6.2.1 North America Rosacea Treatments Market Size by Type (2016-2021)
6.2.2 North America Rosacea Treatments Market Size by Type (2022-2027)
6.2.3 North America Rosacea Treatments Market Size by Type (2016-2027)
6.3 North America Rosacea Treatments Market Size by Application
6.3.1 North America Rosacea Treatments Market Size by Application (2016-2021)
6.3.2 North America Rosacea Treatments Market Size by Application (2022-2027)
6.3.3 North America Rosacea Treatments Market Size by Application (2016-2027)
6.4 North America Rosacea Treatments Market Size by Country
6.4.1 North America Rosacea Treatments Market Size by Country (2016-2021)
6.4.2 North America Rosacea Treatments Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Rosacea Treatments Market Size (2016-2027)
7.2 Europe Rosacea Treatments Market Size by Type
7.2.1 Europe Rosacea Treatments Market Size by Type (2016-2021)
7.2.2 Europe Rosacea Treatments Market Size by Type (2022-2027)
7.2.3 Europe Rosacea Treatments Market Size by Type (2016-2027)
7.3 Europe Rosacea Treatments Market Size by Application
7.3.1 Europe Rosacea Treatments Market Size by Application (2016-2021)
7.3.2 Europe Rosacea Treatments Market Size by Application (2022-2027)
7.3.3 Europe Rosacea Treatments Market Size by Application (2016-2027)
7.4 Europe Rosacea Treatments Market Size by Country
7.4.1 Europe Rosacea Treatments Market Size by Country (2016-2021)
7.4.2 Europe Rosacea Treatments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rosacea Treatments Market Size (2016-2027)
8.2 Asia-Pacific Rosacea Treatments Market Size by Type
8.2.1 Asia-Pacific Rosacea Treatments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rosacea Treatments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rosacea Treatments Market Size by Type (2016-2027)
8.3 Asia-Pacific Rosacea Treatments Market Size by Application
8.3.1 Asia-Pacific Rosacea Treatments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rosacea Treatments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rosacea Treatments Market Size by Application (2016-2027)
8.4 Asia-Pacific Rosacea Treatments Market Size by Region
8.4.1 Asia-Pacific Rosacea Treatments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rosacea Treatments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rosacea Treatments Market Size (2016-2027)
9.2 Latin America Rosacea Treatments Market Size by Type
9.2.1 Latin America Rosacea Treatments Market Size by Type (2016-2021)
9.2.2 Latin America Rosacea Treatments Market Size by Type (2022-2027)
9.2.3 Latin America Rosacea Treatments Market Size by Type (2016-2027)
9.3 Latin America Rosacea Treatments Market Size by Application
9.3.1 Latin America Rosacea Treatments Market Size by Application (2016-2021)
9.3.2 Latin America Rosacea Treatments Market Size by Application (2022-2027)
9.3.3 Latin America Rosacea Treatments Market Size by Application (2016-2027)
9.4 Latin America Rosacea Treatments Market Size by Country
9.4.1 Latin America Rosacea Treatments Market Size by Country (2016-2021)
9.4.2 Latin America Rosacea Treatments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rosacea Treatments Market Size (2016-2027)
10.2 Middle East & Africa Rosacea Treatments Market Size by Type
10.2.1 Middle East & Africa Rosacea Treatments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rosacea Treatments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rosacea Treatments Market Size by Type (2016-2027)
10.3 Middle East & Africa Rosacea Treatments Market Size by Application
10.3.1 Middle East & Africa Rosacea Treatments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rosacea Treatments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rosacea Treatments Market Size by Application (2016-2027)
10.4 Middle East & Africa Rosacea Treatments Market Size by Country
10.4.1 Middle East & Africa Rosacea Treatments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rosacea Treatments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Nestle Skin Health
11.1.1 Nestle Skin Health Company Details
11.1.2 Nestle Skin Health Business Overview
11.1.3 Nestle Skin Health Rosacea Treatments Introduction
11.1.4 Nestle Skin Health Revenue in Rosacea Treatments Business (2016-2021)
11.1.5 Nestle Skin Health Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Rosacea Treatments Introduction
11.2.4 Teva Revenue in Rosacea Treatments Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Rosacea Treatments Introduction
11.3.4 Mylan Revenue in Rosacea Treatments Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Rosacea Treatments Introduction
11.4.4 Bayer Revenue in Rosacea Treatments Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Sun Pharma
11.5.1 Sun Pharma Company Details
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Rosacea Treatments Introduction
11.5.4 Sun Pharma Revenue in Rosacea Treatments Business (2016-2021)
11.5.5 Sun Pharma Recent Development
11.6 Perrigo
11.6.1 Perrigo Company Details
11.6.2 Perrigo Business Overview
11.6.3 Perrigo Rosacea Treatments Introduction
11.6.4 Perrigo Revenue in Rosacea Treatments Business (2016-2021)
11.6.5 Perrigo Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Rosacea Treatments Introduction
11.7.4 Bausch Health Revenue in Rosacea Treatments Business (2016-2021)
11.7.5 Bausch Health Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Rosacea Treatments Introduction
11.8.4 GSK Revenue in Rosacea Treatments Business (2016-2021)
11.8.5 GSK Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Rosacea Treatments Introduction
11.9.4 Pfizer Revenue in Rosacea Treatments Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Rosacea Treatments Introduction
11.10.4 Allergan Revenue in Rosacea Treatments Business (2016-2021)
11.10.5 Allergan Recent Development
11.11 Almirall
11.11.1 Almirall Company Details
11.11.2 Almirall Business Overview
11.11.3 Almirall Rosacea Treatments Introduction
11.11.4 Almirall Revenue in Rosacea Treatments Business (2016-2021)
11.11.5 Almirall Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140